US private equity firm buys 30% of India's Nectar
04 March 2010
Anju Ghangurde
Please Login to read the full article.
04 March 2010
Anju Ghangurde
aghangurde@yahoo.com
The US private equity firm, New Silk Route Partners (NSR), has invested Rs2.52 billion ($54.9 million) in Nectar Lifesciences of India.
Nectar informed the Bombay Stock Exchange that it had raised Rs910 million through an issue of 26 million shares at Rs34 each to the NSR group firm, NSR...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Indian corticosteroids firm Symbiotec attracts $9.4 million private equity funding
- Industry concerned about Indian regulator's timelines and lack of pharma expertise
- M&A activity, pricing pressures seen among the key trends in India in 2012
- Can Indian CRAMS firms cash in on the global slowdown?
COMMENT
Other Informa Comment
EVENTS
Today
London
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
